XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenue $ 5,241 $ 4,643 $ 15,358 $ 13,512
Cost of revenue (COR) 1,624 1,491 4,674 4,486
Gross profit 3,617 3,152 10,684 9,026
Research and development (R&D) 431 388 1,236 1,165
Selling, general and administrative (SG&A) 431 412 1,275 1,262
Acquisition charges 0 47 0 142
Restructuring charges/other 77 0 209 0
Operating profit 2,678 2,305 7,964 6,457
Other income (expense), net (OI&E) 33 15 55 134
Interest and debt expense 53 45 154 135
Income before income taxes 2,658 2,275 7,865 6,456
Provision for income taxes 363 328 1,078 825
Net income $ 2,295 $ 1,947 $ 6,787 $ 5,631
Earnings per common share (EPS):        
Basic (in dollars per share) $ 2.50 $ 2.10 $ 7.35 $ 6.08
Diluted (in dollars per share) $ 2.47 $ 2.07 $ 7.27 $ 5.99
Average shares outstanding:        
Basic (in shares) 913 923 919 923
Diluted (in shares) 923 936 929 936
Diluted EPS:        
Net income $ 2,295 $ 1,947 $ 6,787 $ 5,631
Income allocated to RSUs (11) (9) (30) (24)
Income allocated to common stock for diluted EPS $ 2,284 $ 1,938 $ 6,757 $ 5,607